Business Wire

FRESENIUS KABI ISSUES VOLUNTARY NATIONWIDE RECALL OF THREE LOTS OF FAMOTIDINE INJECTION, USP, 20 MG PER 2 ML (10 MG PER ML), 2 ML FILL IN A 2 ML VIAL DUE TO OUT ...

Famotidine Injection is indicated in some hospitalized patients with pathological hypersecretory conditions or intractable ulcers, or as an alternative to the oral dosage forms for short term use in ...
India Infoline

Zydus receives USFDA approval for Famotidine Injection

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Famotidine Injection USP, 40 mg/4 mL (10 mg/mL) and 200 mg/20 mL (10 mg/mL) ...
India Infoline

Zydus Lifesciences bags final USFDA approval for Famotidine Injection

The United States Food and Drug Administration (USFDA) has given Zydus Lifesciences Limited (formerly Cadila Healthcare Limited) final approval to market Famotidine Injection USP, 40 mg/4 mL (10 mg/mL ...
Pharmabiz

Fresenius Kabi issues voluntary nationwide recall of three lots of Famotidine injection due to out-of-specification endotoxin results

Fresenius Kabi, part of the global healthcare company Fresenius, and a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical ...
Healio

Famotidine does not decrease risk for mortality in COVID-19

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There was no correlation observed between in-hospital ...
MarketWatch

CORRECTING and REPLACING: Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial ...

In the table of the release dated Nov 6, 2025, First Ship Date for Batch Number 6133388 should be 04/15/2025. FRESENIUS KABI ISSUES VOLUNTARY NATIONWIDE RECALL OF THREE LOTS OF FAMOTIDINE INJECTION, ...
The Bakersfield Californian

Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies is voluntarily recalling three lots (numbers 6133156, 6133194, ...
USA Today

Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of ...

FOR IMMEDIATE RELEASE – Nov. 6,2025 – LAKE ZURICH, Ill.— Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies is ...
The Bakersfield Californian

CORRECTING and REPLACING Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial ...

In the table of the release dated Nov 6, 2025, First Ship Date for Batch Number 6133388 should be 04/15/2025.
Yahoo Finance

CORRECTING and REPLACING Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial ...

Three lots (numbers 6133156, 6133194, 6133388) of Famotidine Injection are being recalled in the U.S. by Fresenius Kabi. Three lots (numbers 6133156, 6133194, 6133388) of Famotidine Injection are ...